Torray Investment Partners LLC

Managed by Torray Funds. $698.4M disclosed long-equity portfolio across 95 positions.

#StockValue% of Portfolio
1Broadcom$31.5M4.52%
2Royalty Pharma Plc$28.8M4.12%
3Phillips 66$26.7M3.82%
4Hewlett Packard Ent Ser C Conv$25.0M3.57%
5Texas Instruments$24.3M3.48%
6CNA Financial$23.6M3.37%
7Chevron Corp$22.0M3.15%
8Blackstone$21.5M3.08%
9KKR Series D Conv 6.25$21.5M3.08%
10Abbvie$21.2M3.03%
11Amgen$21.2M3.03%
12Prologis$20.0M2.87%
13Pfizer$20.0M2.87%
14UnitedHealth Group$19.5M2.80%
15PepsiCo$19.5M2.79%
16ONEOK Inc$19.1M2.74%
17NextEra Energy$18.9M2.70%
18Marsh$18.1M2.59%
19Amazon.com$16.7M2.39%
20Microsoft$16.4M2.35%
21Alphabet Cl A$14.8M2.12%
22Intuit$14.3M2.05%
23Apple$13.6M1.95%
24JPMorgan$12.5M1.79%
25Casey's General Stores$9.6M1.37%

For full quarterly history, transactions, and the investor profile, see Torray Funds's page →

More related to Torray Funds 0000098758

Torray Investment Partners LLC — overview

Torray Funds runs Torray Investment Partners LLC, a multi-strategy investment firm tracked here via SEC 13F filings. As of the Q4 2025 13F filing, the disclosed long-equity portfolio is valued at $698M across 95 positions. The largest holdings are Broadcom, Royalty Pharma Plc, and Phillips 66 (Broadcom alone is 4.5% of the book).

Key takeaways

  • Disclosed Q4 2025 portfolio: $698M.
  • Top holdings: Broadcom, Royalty Pharma Plc, and Phillips 66.